Article
Germline mechanisms of immunotherapy toxicities in the era of genome‐wide association studies
28 Jul 2023
Abstract excerpt
Cancer immunotherapy has revolutionized the treatment of advanced cancers and is quickly becoming an option for early-stage disease. By reactivating the host immune system, immunotherapy harnesses patients' innate defenses to eradicate the tumor. By putatively similar mechanisms, immunotherapy can also substantially increase the risk of toxicities or immune-related adverse events (irAEs). Severe irAEs can lead to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
